β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
Background: The possible association between β-adrenoceptor antagonists (β-blockers) and risk of COPD is controversial. The objective of the present study was to test whether β-blocker use is associated with susceptibility to the disease. Methods: A total of 301,542 new users of β-blockers and 1,000...
Main Authors: | Anne Orholm Nielsen, Lars Pedersen, Birgitte Fischer Sode, Morten Dahl |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537019300045 |
Similar Items
-
Danish Register of chronic obstructive pulmonary disease
by: Lange P, et al.
Published: (2016-10-01) -
β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
by: Tse-Hsuan Su, et al.
Published: (2019-01-01) -
Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
by: Goran Nadir Salih, et al.
Published: (2016-09-01) -
Evaluating the effectiveness of β-adrenoceptor blockers in heart failure with or without chronic obstructive pulmonary disease patients
by: Tien-Tu Lin, et al.
Published: (2016) -
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.
by: Line D Rasmussen, et al.
Published: (2013-01-01)